PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
05-Jun-2024 Inspire Names Health Tech Leader Brett Kleger as New CEO Newswire
05-Jun-2024 Bioz and Quantabio Launch AI-Driven Citation Widgets to Provide Researchers With Real-Time Application Data Newswire
04-Jun-2024 Our children deserve better – HOYA Vision Care calls for urgent action to address childhood myopia Hoya Vision Care
04-Jun-2024 Cynthia Hetherington, Founder and CEO of Hetherington Group, Named Association for Corporate Growth New Jersey 2024 Honoree Newswire
03-Jun-2024 Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors Newswire
03-Jun-2024 Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting Grey Wolf Therapeutics
03-Jun-2024 TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team TMC Pharma Services Ltd
03-Jun-2024 Leading Biopharmaceutical Companies Unite to Advance SCE with Domino Domino Data Lab
03-Jun-2024 PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the International Liver Congress — EASL 2024, Including Analytical and Clinical Validation Newswire
31-May-2024 Anocca Appoints Christiane Hanke-Harloff to Board of Directors Anocca
30-May-2024 New Research Study Reveals Critical Role of Magnesium in Regulating Brain Synapses and Cognition Newswire
30-May-2024 Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area Nxera Pharma Co. Ltd
30-May-2024 Result of Placing and Subscription Cambridge Cognition Holdings plc
30-May-2024 POA Pharma announces expansion into Austria, deepening its inborn metabolic disease footprint in Europe Galen Ltd
29-May-2024 Almac Group announces record revenue figure resulting from another year of growth. Revenue reaches $1.169 billion with profit at $114.4 million Almac Group
29-May-2024 Integrated Biosciences Collaborate with Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome Integrated Biosciences
29-May-2024 Novo Holdings portfolio company Numab Therapeutics announces Johnson & Johnson (‘J&J’) to acquire its wholly-owned subsidiary Yellow Jersey Therapeutics, including rights to NM26, a bi-specific antibody for the treatment of atopic dermatitis Novo Holdings
29-May-2024 HiiiWAV Fest Overcomes City Budget Deficit to Launch Oakland’s 1st Music and Tech Festival June 8th Newswire
29-May-2024 Panoramic Health Elevates Kidney Care Innovation With Appointment of Dr. Navdeep Tangri as Senior Advisor for Panoramic Science Newswire
29-May-2024 New Study Quantifies the Impact of Improved Clinical Trial Design Using Faro Health’s Study Designer Tool Newswire